ViewPoint Therapeutics signs license with U-M for potential cataract treatment

12/17/2015

A chemical that could potentially be used in eye drops to reverse cataracts, the leading cause of blindness, has been identified by a team of scientists from the University of Michigan (U-M), UC San Francisco (UCSF) and Washington University in St. Louis (WUSTL)…